Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

Lignende værker

• Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry
  af: Pappas, Dimitrios A., et al.
  Udgivet: (2016)
• Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry
  af: Harrold, Leslie R., et al.
  Udgivet: (2017)
• Greater Likelihood of Remission in Rheumatoid Arthritis Patients Treated Earlier in Disease Course: Results from the CORRONA Registry
  af: Furst, Daniel E., et al.
  Udgivet: (2011)
• Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
  af: Harrold, Leslie R., et al.
  Udgivet: (2015)
• Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
  af: Pappas, Dimitrios A., et al.
  Udgivet: (2021)